Open access
4,589
Views
2
CrossRef citations to date
0
Altmetric
Review
Current status and prospects of IL-6–targeting therapy
Masashi Narazakia Department of Advanced Clinical and Translational Immunology, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan;b Department of Respiratory Medicine, Clinical Immunology, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan;c Department of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-5613-4409View further author information
Tadamitsu Kishimotod Laboratory of Immune Regulation, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, JapanView further author information
Pages 575-592
|
Received 20 Apr 2022, Accepted 27 Jun 2022, Published online: 07 Jul 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.